It’s been nearly a month since omicron’s detection caused alarm because of its large number of mutations. Now preliminary lab research suggests these mutations do appear to boost the variant’s ability to infect even fully vaccinated people, as well as those who have previously had covid.
Numbers don’t lie
What are the numbers looking like in India, predominately, using AstraZeneca vaccine against U.S and U.K that use Modana and Pfizer?
India seems to be holding up well against the Omicron virus.
AstraZeneca vaccine against Omicron
Nearly 2.5 billion doses of the vaccine developed by AstraZeneca and Oxford University vaccine have been supplied globally, and 1.1 billion of them administered in India alone.
A new study reveals that a three-dose course of AstraZeneca’s (AZN.L) COVID-19 vaccine is effective against the rapidly-spreading Omicron coronavirus variant. The pharmaceutical company said on Thursday, citing data from an Oxford University lab study.
Findings from the study, yet to be published in a peer-reviewed medical journal, match those from rivals Pfizer-BioNTech(PFE.N), (22UAy.DE) and Moderna(MRNA.O) which have also found a third dose of their shots works against Omicron.
The study on AstraZeneca’s vaccine, Vaxzevria, showed that after a three-dose course of the vaccine, neutralising levels against Omicron were broadly similar to those against the virus’s Delta variant after two doses.
“As we better understand Omicron, we believe we will find that T-cell response provides durable protection against severe disease and hospitalisations,” Mene Pangalos, the head of AstraZeneca’s biopharmaceuticals R&D said, referring to a critical component of the immune system that respond to fight infection.
India has recorded over 300 Omicron cases so far, with Maharshtra reporting 65 cases, followed by Delhi with 64 cases of the new variant of coronavirus.
Telangana and Tamil Nadu reported 38 cases and 34 cases respectively, while Karnataka and Kerala confirmed 31 and 29 cases of the new variant.
Delhi Chief Minister Arvind Kejriwal held a review meeting on Omicron preparedness on Thursday and said that manpower is being increased and medicine is being arranged to battle the surge in cases.